Guido Magni bought APRE once, on Oct 7, 2019
Director at Aprea Therapeutics, Inc.
SEC CIK 0001437150 · Filings on SEC.gov ↗
Guido Magni's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
1 filing since Oct 2019, newest first
About Guido Magni
Guido Magni, M.D., Ph.D. is a Person and a life sciences investor and executive who serves as a Partner/Managing Director at Versant Ventures, where he focuses on early-stage biotechnology and healthcare investments.( He previously spent about 12 years at Roche, including as Global Head of Medical Science and head of global drug development, overseeing clinical development programs across a broad portfolio of therapeutic products.(
Magni has also served on the boards of several biotechnology companies, including Aprea Therapeutics, where he was a board member before stepping down effective June 30, 2020; Aprea described him as a designated board member in connection with its financing and board activities.( He holds an M.D. and Ph.D. in neuropharmacology from the Università degli Studi di Padova.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.